Ventilator Care Bundle

Slides:



Advertisements
Similar presentations
The Eradication of VAP in Scotland Martin Hughes Nov 2010.
Advertisements

Prevention of Ventilator Associated Pneumonia
Peter Lucas Karin Schurink Marc Bonten Stefan Visscher Using a Bayesian-network Model for the Analysis of Clinical Time-series Data University Medical.
H CAP & H AP Pamela Charity, MD Cathryn Caton, MD, MS.
Rohit M. Jangi, MD Medical Director, Bethany Health Care Center
Implementing a Ventilator-Associated Pneumonia Bundle in an Academic Emergency Department L.A. DeLuca, L.R. Stoneking, K. Grall, A. Tran, J. Rosell, A.
Patient safety bundles for critical care
OUR LADY OF LOURDES MEMORIAL HOSPITAL Binghamton, New York Reducing Complications From Ventilators in ICU: Ventilator Associated Pneumonia (VAP)
Ventilator Associated Pneumonia (VAP)
Health Care Associated Pneumonia Respiratory Block
Sean Berenholtz, MD MHS FCCM September 20, 2011 at 2ET/1 CT/12 MT/11 PT Ventilator Associated Pneumonia Prevention CLABSI Supplemental Call Series.
Ventilator-Associated Pneumonia. Introduction Definition 48 hours after intubation mechanically ventilated No clinical evidence of pneumonia prior to.
Journal Club. Background to the paper Pneumonia is THE MOST COMMON nosocomial infection in ICU patients 12 to 18 cases per 1000 ventilator days Oropharyngeal.
Current Challenges in the ICU Prof Craig Williams Institute of Healthcare Associated Infection UWS.
Ventilator Associated Pneumonia Overview
American Association of Critical-Care Nurses: Practice Alert
Safer Healthcare Now! Ventilator Acquired Pneumonia Presented by Amanda Thompson, Safer Healthcare Now Facilitator April 12, 2007.
Preventing VAP - evidence for a care bundle. VAP Incidence ~ % ventilated patients 7-15 / 1000 ventilator days Atributable mortality of 0-50% Atributable.
Biofilms on Medical Devices
H CAP & H AP Pamela Charity, MD Cathryn Caton, MD, MS.
Prevention of Nosocomial Infections
CLABSI: Working Toward Zero Trinity Regional Health System Infection Prevention and Control Presented by: Patricia Herath, BSN, RNC Infection Preventionist.
Oral Care for Patients at Risk for Ventilator-Associated Pneumonia Issued April 2010.
GENERAL TEMPLATE FOR A 48”X36” POSTER Name(s) of Author(s) 1 ; Name(s) of Author(s) 2 ; Name(s) of Author(s) 3 1. Name of Institution; 2. Name on Institution;
VAP Intervention Information
Patient- and Family-Centered Care — What is it? Patient- and family- centered care is working with, rather than doing to or for.
Health Care Associated Pneumonia Respiratory Block BY PROF.A.M.KAMBAL and PROF.HANAN HABIB Department of Pathology, KSU.
Hospital Acquired Infections Ernest Oppong & Leyla Chiepodeu University of Virginia’s College at Wise Nursing BACKGROUNDPURPOSE Hospital associated infections.
Nosocomial Pneumonia Hospital Acquired, Ventilator Associated, Healthcare Associated Pneumonia.
Clinical Uses and Ramifications of VAE Data
PRESENTER: HALIMATUL NADIA M HASHIM SUPERVISOR: DR NIK AZMAN NIK ADIB.
The Role of Thromboprophylaxis in Elective Spinal Surgery The Role of Thromboprophylaxis in Elective Spinal Surgery VA Elwell, N Koo Ng, D Horner & D Peterson.
Part I BACKGROUND VENTILATOR ASSOCIATED PNEUMONIA.
Pneumonia Dr. Abdul-Monim Batiha Assistant Professor Critical Care Nursing Philadelphia university.
ความหมาย As Pneumonia in patient who have been on mechanical ventilation for greater than 48 hrs.
Linking Research, Audit, Quality Improvement and Evidence- Based Medicine Dr Chris Cairns 2010.
Nosocomial Pneumonia Epidemiology Common hospital-acquired infection Occurs at a rate of approximately 5-10 cases per 1000 hospital admissions Incidence.
Adv Dip (Med Sci), MBBS, MBA (Healthcare Management)
Hospital Acquired Pneumonia(HAP): is defined as a pneumonia which occurs after 48 hours of admission to hospital. Hospital Acquired Pneumonia(HAP): is.
Mini BAL v/s Bronchoscopic BAL PROF. PRADYUT WAGHRAY MD (CHEST), DTCD, FCCP (USA),D.SC(PULM. MEDICINE) HEAD OF DEPT. OF PULMONARY MEDICINE S.V.S MEDICAL.
CUSP 4 MVP – VAP Improving Care for Mechanically Ventilated Patients Data Feedback: SubG ETT, Head of Bed Elevation and Delirium Assessment Utilization.
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals 2014 Update Dr Neda Alijani.
Copenhagen University Hospital Rigshospitalet, Denmark
Ventilator-associated pneumonia (VAP) Ventilator-associated pneumonia (VAP) is defined as nosocomial pneumonia in a patient on mechanical ventilatory support.
Process and Outcome Measures Ventilator Management Redesign Effort.
PREVENTION Kaplan University Capstone NU499 VENTILATOR – ASSOCIATED PNEUMONIA VAP PREVENTION at Sparks Regional Medical Center.
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
ICU Nosocomial Pneumonia
Diamantis P. Kofteridis, Christina Alexopoulou, Antonios Valachis, Sofia Maraki, Dimitra Dimopoulou Clinical Infectious Diseases 2010; 51(11):1238–1244.
Cellulitis Darren Wilson Antibiotic Pharmacist Royal Bournemouth Hospital.
Ventilator Associated Pneumonia. Ventilator-associated pneumonia (VAP) is a form of hospital-associated pneumonia (HAP) which develops in mechanically.
Is a Strategy Based on Routine Endotracheal Cultures the Best Way to Prescribe Antibiotics in Ventilator-Associated Pneumonia? CHEST 2013; 144(1):63-71.
VAE/VAP: Definitions, Algorithms and Best Practices
Poster template by ResearchPosters.co.za Ventilator Associated Pneumonia rates in Intensive Care. Lori J. Delaney Assistant Professor: University of Canberra,
Depart. Of Pulmonology and Critical Care Medicine R4 백승숙.
Ventilator-Associated Pneumonia
Update in Critical Care Medicine Ann Intern Med 2007;147:
Pattern of Hospital-Acquired Pneumonia in Intensive Care Unit of Suez Canal University Hospital By Nermine El-Maraghy Associate Professor of Medical Microbiology.
Health Care Associated Pneumonia Respiratory Block
Ventilator-associated pneumonia (VAP) prevention in Wales:
Advanced Ventilation Research
Health Care Associated Pneumonia
Subglottic Suctioning
Health Care Associated Pneumonia Respiratory Block
A Quick Review: Preventing Ventilator-Associated Pneumonia (VAP)
Surveillance of Post-operative pneumonia
Health Care Associated Pneumonia
Cardiff and Vale UHB Dr Graham Shortland
Health Care Associated Pneumonia Respiratory Block
Presentation transcript:

Ventilator Care Bundle Assignment – Critical care Nursing OUM Dr. S.N. Silva (MBBS)

VENTILATOR ASSOCIATED PNEUMONIA

AIMS AND OBJECTIVES To present a clinical case illustrating the problem of ventilator-associated pneumonia (VAP) To discuss the diagnosis and management of VAP, along with a review of the evidence To highlight controversies in dealing with VAP

CASE PRESENTATION BB 73 M Presented to SMH with 10/7 history of “laryngitis” Cough/SOB/Fever

CASE PRESENTATION PMHx DHx Prostate Ca Bilateral TKRs for OA Hypertension DHx Antihypertensives Zoladex NKDA

CASE PRESENTATION Initially managed on medical ward However, deteriorated 1/7 into admission: Tachycardia/hypotension/tachypnoea Transferred to ICU, deteriorated further Intubated Ventilated. Needing high FiO2/PEEP Inotropic support Broad spectrum antibiotics Over 2/52, gradual improvement. Antibiotics stopped

CASE PRESENTATION Improving- FiO2 now 40%, PEEP 8 Tracheostomy for weaning Then deterioration: FiO2 60% to maintain PO2 8 Tachypnoea Pyrexia

???

WHAT IS VAP? Er, noone really knows Suggested diagnostic criteria: New CXR changes and one of: Fever Leukocytosis Increasingly purulent secretions 48 hours or longer after institution of mechanical ventilation Confirmation by microbiological sampling (BAL/tracheal brushings)

WHAT IS VAP? Wide range of organisms: Gram positive: Gram negative: Staph Aureus (both MSSA and MRSA) Streptococcus Gram negative: Pseudomonas Acinetobacter Klebsiella Others: Candida/Aspergillus Viruses (rare)

WHO GETS VAP? Host Environment Age Sex (M>F) Underlying disease state (chronic disease, conscious level, sepsis etc) Intubation Length of ventilation Tube cuff pressure Reintubation Sedation Body postion* Use of gastric protection* NG feeding Unit hygiene* People being mechanically ventilated (Both ETT and tracheostomy) Risk factors:

WHY IS IT IMPORTANT? We see it all the time (27% of ICU patients) Mortality 27-76% (!)*

WHY IS IT IMPORTANT?

WHAT SHOULD WE DO? Identify the at risk patient Reduce the risks Rapidly diagnose VAP when it occurs Treat appropriately

REDUCING THE RISKS “Care bundles” Series of intervention grouped together as a single one Worked well with central venous catheters (“Matching Michigan”)*

REDUCING THE RISKS Elevation of bed 30-45 degrees* DVT prophylaxis Humidification Oral hygiene/chlorhexidine mouthwash* Gastric ulcer prophylaxis* Appropriate ventilator tubing management Suctioning of oropharyngeal secretions Sedation holding/review

REDUCING THE RISKS (Extra stuff from Europe) Microbiological surveillance Low nurse:patient ratio Reduce antimicrobial prescriptions Orotracheal tubes/orogastric tubes Maintaining ETT cuff pressure >20cmH20 Subglottic aspiration* Antiseptic coated ETTs*

ORAL DECONTAMINATION WITH CHLORHEXIDINE Simple Cheap Quite safe Makes sense

SELECTIVE DIGESTIVE DECONTAMINATION Similar principle, but involves using oral decontamination + NG tube antibiotics + IV antibiotics in a variety of recipes Same principle as above

GASTRIC ULCER PROPHYLAXIS Reduces risk of ventilator associated stress ulcers… But INCREASES risk of VAP What to do?

GASTRIC ULCER PROPHYLAXIS “No single strategy of stress ulcer prophylaxis is preferred when mortality is used as the outcome. In the absence of a clinical trial demonstrating survival benefit the individual clinician's assumptions regarding the effect of prophylaxis on gastrointestinal bleeding and pneumonia and the attributable mortality of pneumonia vs. gastrointestinal bleeding will have a significant effect on the decision”.

RAPID DIAGNOSIS Sensitivity 77%, specificity 42%  Other biomarkers being searched for- none yet (Procalcitonin/CRP useful treatment monitors, but not so useful for diagnosis)

RAPID,SPECIFIC TREATMENT Start treatment early when suspected Broad-spectrum antibiotic (with antipseudomonal activity) +/- aminoglycoside recommended

Assignment Define terms VCB – ? VAP – OUM has done Critically ill patient - ? Critically ill patient with VAP

Then….. Discuss using VCB Significance of using VCB Critically Discuss VCB

Ventilator Associated Pneumonia Multiple factors should be considered when addressing the issues of HAP and VAP. These factors include the following: Whether or not to intubate the patient The route of intubation or placement of tubes Feeding the patient Body positioning Prevention of stress-related bleeding Prevention of deep venous thrombosis Use of antibiotics and control of colonization http://emedicine.medscape.com/article/304836-overview

Ventilator Associated Pneumonia Who / When/ What? http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1592694/ While critically ill patients experience a life-threatening illness, they commonly contract ventilator-associated pneumonia. This nosocomial infection increases morbidity and likely mortality as well as the cost of health care. This article reviews the literature with regard to diagnosis, treatment, and prevention. It provides conclusions that can be implemented in practice as well as an algorithm for the bedside clinician and also focuses on the controversies with regard to diagnostic tools and approaches, treatment plans, and prevention strategies.

Significance “The application of the VAP bundle in chronic ventilated patients resulted in a significant reduction in the incidence of VAP. ” http://ccforum.com/content/12/S2/P433

Significance “Initiation of the VAP bundle is associated with a significantly reduced incidence of VAP in patients in the SICU and with cost savings.” http://apicwv.org/docs/40.pdf

Critically? “The ventilator bundle should be modified and expanded to include specific processes of care that have been definitively demonstrated to be effective in VAP reduction or a specific VAP bundle created to focus on VAP prevention. ” http://www.ncbi.nlm.nih.gov/pubmed/19276975

Critically ? “Individual elements did not appear effective; strict compliance with infection elements was needed. Efforts to prevent VAP may be successful in settings of high levels of compliance with all infection-specific elements and in settings with full-time HEs.” http://www.cumc.columbia.edu/studies/pnice/pdf/Pogorzelska.pdf